标题/作者	年份
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice RR Razonable, A Humar Clinical transplantation 33 (9), e13512	2019
The middle east respiratory syndrome (MERS) EI Azhar, DSC Hui, ZA Memish, C Drosten, A Zumla Infectious Disease Clinics 33 (4), 891-905	2019
BK polyomavirus in solid organ transplantation—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice HH Hirsch, PS Randhawa, ... Clinical transplantation 33 (9), e13528	2019
Long-term survival after kidney transplantation S Hariharan, AK Israni, G Danovitch New England Journal of Medicine 385 (8), 729-743	2021
Pathogenesis of human cytomegalovirus in the immunocompromised host P Griffiths, M Reeves Nature Reviews Microbiology 19 (12), 759-773	2021
The expanding field of secondary antibody deficiency: causes, diagnosis, and management SY Patel, J Carbone, S Jolles Frontiers in immunology 10, 33	2019
Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials RF Chemaly, S Chou, H Einsele, P Griffiths, R Avery, RR Razonable, ... Clinical Infectious Diseases 68 (8), 1420-1426	2019
Nelson's pediatric antimicrobial therapy JS Bradley American Academy of Pediatrics	2012
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir‐resistant cytomegalovirus infection L Cherrier, A Nasar, KJ Goodlet, MD Nailor, S Tokman, S Chou American Journal of Transplantation 18 (12), 3060-3064	2018
Impact of COVID-19 in solid organ transplant recipients L Danziger-Isakov, EA Blumberg, O Manuel, M Sester American Journal of Transplantation 21 (3), 925-937	2021
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review G El Helou, RR Razonable Infection and drug resistance, 1481-1491	2019
Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial N Singh, DJ Winston, RR Razonable, GM Lyon, FP Silveira, MM Wagener, ... Jama 323 (14), 1378-1387	2020
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance J Piret, G Boivin Antiviral research 163, 91-105	2019
Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial RK Avery, S Alain, BD Alexander, EA Blumberg, RF Chemaly, ... Clinical Infectious Diseases 75 (4), 690-701	2022
Common viral infections in kidney transplant recipients J Vanichanan, S Udomkarnjananun, Y Avihingsanon, K Jutivorakool Kidney Research and Clinical Practice 37 (4), 323	2018
A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients D Kumar, P Chin‐Hong, L Kayler, D Wojciechowski, AP Limaye, ... American Journal of Transplantation 19 (9), 2505-2516	2019
Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence G Haidar, M Boeckh, N Singh The Journal of infectious diseases 221 (Supplement_1), S23-S31	2020
Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression” MB Roberts, JA Fishman Clinical Infectious Diseases 73 (7), e1302-e1317	2021
Lung transplantation in idiopathic pulmonary fibrosis R Laporta Hernandez, M Aguilar Perez, MT Lázaro Carrasco, P Ussetti Gil Medical sciences 6 (3), 68	2018
Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis N Leeaphorn, N Garg, N Thamcharoen, EV Khankin, F Cardarelli, ... American Journal of Transplantation 19 (2), 573-584	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。